InspireMD to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

BOSTON, MA – September 1, 2015 – InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems (“EPS”) and thrombus management technologies, today announced that its Chief Executive Officer, Alan Milinazzo, will present at the Rodman & Renshaw 17th Annual Global Conference on Thursday, September 10, 2015 at 10:25 a.m. ET. The conference will be held in New York, NY.

A live webcast will be available for those participants who are unable to attend, which can be found at: The webcast will be available for 180 days following the presentation.


About InspireMD, Inc.

InspireMD ( seeks to utilize its proprietary MGuard™ with MicroNet™TM technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this MicroNet™ technology in coronary, carotid (CGuardTM), neurovascular, and peripheral artery procedures. InspireMD’s common stock is quoted on the NYSE MKT under the ticker symbol NSPR.


 Investor Contacts:

InspireMD, Inc.
Craig Shore
Chief Financial Officer
Phone: 1-888-776-6804

PCG Advisory
Vivian Cervantes
Investor Relations
Phone: (212) 554-5482